If you need more lookups,
subscriptions start at $34 USD/month.
Andreas Mershin Location
Cambridge, MA, US
Andreas Mershin Work
Chief Science Officer @ (July 2023 - Present)
President and co-founder @ (October 2021 - Present)
Head of Science @ MycoHAB - Myconic (April 2020 - Present)
Lecturer @ MIT Sloan Executive Education (January 2014 - Present)
Director of Science @ (July 2022 - July 2023)
Research Scientist, Center for Bits and Atoms @ (June 2011 - June 2023)
Research Scientist @ (August 2004 - June 2011)
Molecular Frontiers Inquiry Prize Director and co-founder @ Molecular Frontiers Foundation (August 2006 - January 2019)
Lead Organizer @ Hellenic Business Network (January 2005 - December 2007)
Andreas Mershin Education
Massachusetts Institute of Technology
PostDoc (Bio-nano-tech)
2004-2007
Texas A&M University
PhD (Physics)
1997-2003
Imperial College London
MSci (Physics)
1993-1997
Andreas Mershin Skills
Entrepreneurship
Nanotechnology
Biophysics
Bioengineering
Biomedical Engineering
Biomaterials
Nanomaterials
Materials Science
Renewable Energy
photovoltaics
biophotovoltaics
Quantum effects in biology
Label-free molecular interaction techniques
Machine olfaction
Synthetic Biology
Prototyping
Quantified Self
Physics
Enthusiast
Inspirer
Experimentation
LaTeX
Molecular Biology
Fluorescence
Mathematica
Spectroscopy
Protein Chemistry
Characterization
Biochemistry
Fortran
Science
Research
Matlab
Andreas Mershin Summary
Andreas Mershin, based in Cambridge, MA, US, is currently a Chief Science Officer at RealNose Inc.. Andreas Mershin brings experience from previous roles at Osmocosm, MycoHAB - Myconic, MIT Sloan Executive Education and Scentient. Andreas Mershin holds a 2004 - 2007 PostDoc in Bio-nano-tech @ Massachusetts Institute of Technology. With a robust skill set that includes Entrepreneurship, Nanotechnology, Biophysics, Bioengineering, Biomedical Engineering and more. Andreas Mershin has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Andreas Mershin?
Find contact details for 700 million professionals.